Bio-Techne Corporation acquired Atlanta Biologicals, Inc. And Scientific Ventures, Inc. on January 2, 2018. The transaction is financed through available cash on hand and revolving line of credit facility. The acquisition is expected to be slightly accretive to Bio-Techne's adjusted earnings per share for its fiscal year 2018. Fredrikson & Byron, P.A. acted as legal advisor for Bio-Techne. Benchmark International acted as financial advisor and Morris, Manning & Martin LLP acted as legal advisor for Atlanta Biologicals. Bio-Techne Corporation completed the acquisition of Atlanta Biologicals, Inc. And Scientific Ventures, Inc. for approximately $50 million on January 2, 2018.